Transcat named one of America’s Best Small Companies by Forbes

ROCHESTER, N.Y.--(BUSINESS WIRE)-- Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today announced that Forbes has named it one of America's top 100 small companies for 2022 in its recently released list. Transcat was ranked 75th on the list with a 52-week return of 181.6 percent.

Forbes identified the best performers using data from FactSet, evaluating more than 1,000 companies that have been public for more than a year, with a market value between $300 million and $2 billion to find 509 companies that also had positive sales growth over the past 12 months and a share price of at least $5. The top ranking was determined based on earnings and sales growth, return on equity and total stock return for the latest 12 months available and over the last five years, with more weight given to the latest year's data. For the full list of Forbes' best small companies, visit: https://www.forbes.com/lists/best-small-cap-companies/#1c5b940847db.

"We are pleased to be recognized as one of the country's best small companies by Forbes," said Lee Rudow, President and CEO of Transcat. "The strong operating and financial performance the company has achieved over the last several years is the result of the hard work and solid execution of our strategy by our dedicated team that continues to get stronger. Additionally, we believe our unique value proposition for our customers will continue to allow us to capture share in highly regulated markets, including life sciences, and help drive our future growth.”

ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection, and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found at: Transcat.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005084/en/

Mark A. Doheny, Chief Financial Officer

Phone: (585) 563-5766

Email: mark.doheny@transcat.com

Source: Transcat, Inc.